NMDA receptors in clinical neurology: excitatory times ahead
Top Cited Papers
- 1 August 2008
- journal article
- review article
- Published by Elsevier in The Lancet Neurology
- Vol. 7 (8) , 742-755
- https://doi.org/10.1016/s1474-4422(08)70165-0
Abstract
No abstract availableKeywords
This publication has 142 references indexed in Scilit:
- Prion protein attenuates excitotoxicity by inhibiting NMDA receptorsThe Journal of cell biology, 2008
- Riluzole enhances the activity of glutamate transporters GLAST, GLT1 and EAAC1European Journal of Pharmacology, 2007
- Enhanced cell death in MeCP2 null cerebellar granule neurons exposed to excitotoxicity and hypoxiaPublished by Elsevier ,2007
- Differential binding properties of [3H]dextrorphan and [3H]MK-801 in heterologously expressed NMDA receptorsNeuropharmacology, 2005
- Memantine Treatment in Patients With Moderate to Severe Alzheimer Disease Already Receiving DonepezilJAMA, 2004
- Efficacy and safety of xaliproden in amyotrophic lateral sclerosis: results of two phase III trialsAmyotrophic Lateral Sclerosis, 2004
- Efficacy and Safety of Memantine in Patients With Mild to Moderate Vascular DementiaStroke, 2002
- Targeting the N-Methyl-d-Aspartate Receptor for Chronic Pain ManagementJournal of Pain and Symptom Management, 2000
- Felbamate in the Treatment of Lennox‐Gastaut Syndrome: Results of a 12‐Month Open‐Label Study Following a Randomized Clinical TrialEpilepsia, 1993
- A qualitative and quantitative evaluation of amantadine in the treatment of Parkinson's diseaseJournal of Chronic Diseases, 1972